The Effect of Vitamin D Deficiency on Overgrowth of Uterine Fibroids: A Blinded Randomized Clinical Trial

Overview

Journal Int J Fertil Steril

Specialty Reproductive Medicine

Date 2021 Mar 9

PMID 33687161

Citations 6

Authors

Fatemeh Davari Tanha

Elham Feizabad

Maryam Vasheghani Farahani

Hoora Amuzegar

Behnaz Moradi

Saghar Samimi Sadeh

Affiliations

Soon will be listed here.

Abstract

Background: To evaluate the effects of vitamin D (vitD) supplement on uterine fibroid growth.

Materials And Methods: A randomized blinded clinical trial was conducted at a tertiary university-based hospital from August 2017 to September 2018. Totally, 204 women were enrolled into the study. They had at least one uterine fibroid >10 mm on transvaginal ultrasound and their vitD level was insufficient (i.e. 20-30 ng/ml). The intervention group was treated with vitD 50000 U supplements for two months. After 2 months, ultrasound screening and vitD level measurement was done in both groups.

Results: At first, the mean serum vitD levels in intervention and control group were 23.62 and 23.20 ng/ml, respectively. After 8 weeks, the mean serum vitD levels in the control and intervention group were 22.72 and 28.56 ng/ml respectively (P<0.05). Also, mean fibroma diameter in the intervention group before and after 8 weeks of vitD supplementation was 43 ± 4.68 and 42.6 ± 1.31 mm, respectively. Mean uterine fibroid diameter in the control group which did not receive vitD supplements, before and after 8 weeks was 41.98 ± 5.25 and 47.81 ± 3.42 mm, respectively. The variation in the mean size of the uterine fibroid between the control and intervention group which was respectively about 5.83 mm increase and 0.48 mm decrease, was significant (P<0.001).

Conclusion: Our results showed that vitD supplementation prevents fibroid growth. It seems that vitD supplement is a simple, safe and inexpensive modality for leiomyoma growth prevention (Registration number: IRCT201703122576N15).

Citing Articles

Can We Treat Racism with Baby Aspirin?.

Madueke-Laveaux O, Tanna R, Al-Hendy A Curr Opin Gynecol Obstet. 2023; 5(1):462-466.

PMID: 38093953 PMC: 10718571.

Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach).

Vafaei S, Ciebiera M, Omran M, Mousaei Ghasroldasht M, Yang Q, Leake T Int J Mol Sci. 2023; 24(21).

PMID: 37958957 PMC: 10648339. DOI: 10.3390/ijms242115972.

Vitamin D and uterine fibroid growth, incidence, and loss: a prospective ultrasound study.

Harmon Q, Patchel S, Denslow S, LaPorte F, Cooper T, Wise L Fertil Steril. 2022; 118(6):1127-1136.

PMID: 36150919 PMC: 9771933. DOI: 10.1016/j.fertnstert.2022.08.851.

Association of Vitamin D Anabolism-Related Gene Polymorphisms and Susceptibility to Uterine Leiomyomas.

Xie S, Jiang M, Liu H, Xue F, Chen X, Zhu X Front Genet. 2022; 13:844684.

PMID: 35795205 PMC: 9251306. DOI: 10.3389/fgene.2022.844684.

Dietary Natural Compounds and Vitamins as Potential Cofactors in Uterine Fibroids Growth and Development.

Szydlowska I, Nawrocka-Rutkowska J, Brodowska A, Marciniak A, Starczewski A, Szczuko M Nutrients. 2022; 14(4).

PMID: 35215384 PMC: 8880543. DOI: 10.3390/nu14040734.

References

Stewart E . Uterine fibroids. Lancet. 2001; 357(9252):293-8. DOI: 10.1016/S0140-6736(00)03622-9. View

Fichera M, Torok P, Tesarik J, Della Corte L, Rizzo G, Garzon S . Vitamin D, reproductive disorders and assisted reproduction: evidences and perspectives. Int J Food Sci Nutr. 2020; 71(3):276-285. DOI: 10.1080/09637486.2019.1661978. View

Donnez J, Dolmans M . Uterine fibroid management: from the present to the future. Hum Reprod Update. 2016; 22(6):665-686. PMC: 5853598. DOI: 10.1093/humupd/dmw023. View

Al-Hendy A, Badr M . Can vitamin D reduce the risk of uterine fibroids?. Womens Health (Lond). 2014; 10(4):353-8. PMC: 4209245. DOI: 10.2217/whe.14.24. View

Lagana A, Vitale S, Ban Frangez H, Vrtacnik-Bokal E, DAnna R . Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal. Eur Rev Med Pharmacol Sci. 2017; 21(18):4243-4251. View

Eldar-Geva T, Healy D . Other medical management of uterine fibroids. Baillieres Clin Obstet Gynaecol. 1999; 12(2):269-88. DOI: 10.1016/s0950-3552(98)80064-3. View

Baird D, Hill M, Schectman J, Hollis B . Vitamin d and the risk of uterine fibroids. Epidemiology. 2013; 24(3):447-53. PMC: 5330388. DOI: 10.1097/EDE.0b013e31828acca0. View

Ciebiera M, Wlodarczyk M, Ciebiera M, Zareba K, Lukaszuk K, Jakiel G . Vitamin D and Uterine Fibroids-Review of the Literature and Novel Concepts. Int J Mol Sci. 2018; 19(7). PMC: 6073230. DOI: 10.3390/ijms19072051. View

Yang Q, Mas A, Diamond M, Al-Hendy A . The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development. Reprod Sci. 2015; 23(2):163-75. PMC: 5933172. DOI: 10.1177/1933719115584449. View

10.

Mitro S, Zota A . Vitamin D and uterine leiomyoma among a sample of US women: Findings from NHANES, 2001-2006. Reprod Toxicol. 2015; 57:81-6. PMC: 4550549. DOI: 10.1016/j.reprotox.2015.05.013. View

11.

Lagana A, Vergara D, Favilli A, La Rosa V, Tinelli A, Gerli S . Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease. Arch Gynecol Obstet. 2017; 296(5):855-867. DOI: 10.1007/s00404-017-4515-5. View

12.

Kaplan Z, Tasci Y, Topcu H, Erkaya S . 25-Hydroxy vitamin D levels in premenopausal Turkish women with uterine leiomyoma. Gynecol Endocrinol. 2017; 34(3):261-264. DOI: 10.1080/09513590.2017.1391774. View

13.

Holick M . Vitamin D: A millenium perspective. J Cell Biochem. 2003; 88(2):296-307. DOI: 10.1002/jcb.10338. View

14.

Matyjaszek-Matuszek B, Lenart-Lipinska M, Wozniakowska E . Clinical implications of vitamin D deficiency. Prz Menopauzalny. 2015; 14(2):75-81. PMC: 4498026. DOI: 10.5114/pm.2015.52149. View

15.

Al-Hendy A, Myers E, Stewart E . Uterine Fibroids: Burden and Unmet Medical Need. Semin Reprod Med. 2017; 35(6):473-480. PMC: 6193285. DOI: 10.1055/s-0037-1607264. View

16.

Colonese F, La Rosa V, Lagana A, Vitale S, Cortinovis D, Bidoli P . Comment on: "Is there a role for vitamin D in human reproduction?". Horm Mol Biol Clin Investig. 2016; 29(1):37-38. DOI: 10.1515/hmbci-2016-0040. View

17.

Brakta S, Diamond J, Al-Hendy A, Diamond M, Halder S . Role of vitamin D in uterine fibroid biology. Fertil Steril. 2015; 104(3):698-706. PMC: 4561014. DOI: 10.1016/j.fertnstert.2015.05.031. View

18.

Gonzalez-Mateo G, Fernandez-Millara V, Bellon T, Liappas G, Ruiz-Ortega M, Lopez-Cabrera M . Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production. PLoS One. 2014; 9(10):e108477. PMC: 4184804. DOI: 10.1371/journal.pone.0108477. View

19.

Ali M, Al-Hendy A, Yang Q . Vitamin D, a promising natural compound with anti-uterine fibroid characteristics. Fertil Steril. 2019; 111(2):268-269. DOI: 10.1016/j.fertnstert.2018.11.004. View

20.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View